Repligen: Rare Growth In The Biopharma Supplies Industry [Seeking Alpha]
Repligen Corporation (RGEN)
Last repligen corporation earnings: 2/20 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
repligen.com/investors
Company Research
Source: Seeking Alpha
RGEN's strong balance sheet, recurring organic growth, and strategic acquisitions position it for continued outperformance despite sector volatility. The current depressed valuation and stable financials make RGEN attractive for long-term investors seeking bioprocessing exposure. Adding RGEN shares on a recurring basis is recommended to capitalize on a potential sector normalization before future upside. XH4D/iStock via Getty Images Introduction As one of the first biopharma suppliers to rebound over the past few months, Repligen ( RGEN ) is a case in true secular opportunity. As I discussed in my latest article on Sartorius ( This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of RGEN either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any c
Show less
Read more
Impact Snapshot
Event Time:
RGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RGEN alerts
High impacting Repligen Corporation news events
Weekly update
A roundup of the hottest topics
RGEN
News
- Repligen (NASDAQ:RGEN) had its "sell (d+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Repligen Corporation to Present at Evercore Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Repligen Corporation to Present at Evercore Healthcare ConferenceGlobeNewswire
- Why Repligen (RGEN) Stock Is Trading Up Today [Yahoo! Finance]Yahoo! Finance
- Repligen (NASDAQ:RGEN) had its "sell (d+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
RGEN
Earnings
- 10/28/25 - Beat
RGEN
Sec Filings
- 11/26/25 - Form 4
- 11/25/25 - Form 144
- 11/19/25 - Form 4
- RGEN's page on the SEC website